230 related articles for article (PubMed ID: 23339480)
21. Selenium-Platinum Coordination Dendrimers with Controlled Anti-Cancer Activity.
Li T; Smet M; Dehaen W; Xu H
ACS Appl Mater Interfaces; 2016 Feb; 8(6):3609-14. PubMed ID: 26390019
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis-inducing agents: a patent review (2010 - 2013).
Kamal A; Faazil S; Malik MS
Expert Opin Ther Pat; 2014 Mar; 24(3):339-54. PubMed ID: 24405450
[TBL] [Abstract][Full Text] [Related]
23. Recent progress in dendrimer-based nanomedicine development.
Kim Y; Park EJ; Na DH
Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
[TBL] [Abstract][Full Text] [Related]
24. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
25. Targeting syndecans: a promising strategy for the treatment of cancer.
Choi S; Kang DH; Oh ES
Expert Opin Ther Targets; 2013 Jun; 17(6):695-705. PubMed ID: 23421390
[TBL] [Abstract][Full Text] [Related]
26. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.
Yao H; Veine DM; Fay KS; Staszewski ED; Zeng ZZ; Livant DL
Breast Cancer Res Treat; 2011 Jan; 125(2):363-75. PubMed ID: 20300829
[TBL] [Abstract][Full Text] [Related]
27. Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation.
Wang F; Cai X; Su Y; Hu J; Wu Q; Zhang H; Xiao J; Cheng Y
Acta Biomater; 2012 Dec; 8(12):4304-13. PubMed ID: 22842039
[TBL] [Abstract][Full Text] [Related]
28. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
Giordanetto F; Karis D
Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
[TBL] [Abstract][Full Text] [Related]
29. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
31. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
32. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).
Collina S; Bignardi E; Rui M; Rossi D; Gaggeri R; Zamagni A; Cortesi M; Tesei A
Expert Opin Ther Pat; 2017 May; 27(5):565-578. PubMed ID: 28051882
[TBL] [Abstract][Full Text] [Related]
33. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
34. Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381).
Lipka DB; Kuck D; Kliem C; Gerhauser C
Expert Opin Ther Pat; 2013 Apr; 23(4):537-43. PubMed ID: 23448241
[TBL] [Abstract][Full Text] [Related]
35. Dendrimers in oncology: an expanding horizon.
Tekade RK; Kumar PV; Jain NK
Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
[No Abstract] [Full Text] [Related]
36. Molecularly targeted cancer therapy: some lessons from the past decade.
Huang M; Shen A; Ding J; Geng M
Trends Pharmacol Sci; 2014 Jan; 35(1):41-50. PubMed ID: 24361003
[TBL] [Abstract][Full Text] [Related]
37. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
38. Terpenoids: natural products for cancer therapy.
Huang M; Lu JJ; Huang MQ; Bao JL; Chen XP; Wang YT
Expert Opin Investig Drugs; 2012 Dec; 21(12):1801-18. PubMed ID: 23092199
[TBL] [Abstract][Full Text] [Related]
39. Dendrimers - from organic synthesis to pharmaceutical applications: an update.
Kalhapure RS; Kathiravan MK; Akamanchi KG; Govender T
Pharm Dev Technol; 2015 Jan; 20(1):22-40. PubMed ID: 24299011
[TBL] [Abstract][Full Text] [Related]
40. Combining unique properties of dendrimers and magnetic nanoparticles towards cancer theranostics.
Chandra S; Nigam S; Bahadur D
J Biomed Nanotechnol; 2014 Jan; 10(1):32-49. PubMed ID: 24724497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
